Skin conditions (dermatitis, eczema, psoriasis) decisions — 2025

The Board has reopened the claims for service connection for rib disorder, reflex sympathetic dystrophy, fibromyalgia, respiratory disorder, skin condition, to include psoriasis, bilateral hand arthritis, bilateral carpal tunnel syndrome, and bilateral ulnar neuropathy. However, the claims for service connection for bilateral hand arthritis, bilateral carpal tunnel syndrome, bilateral ulnar neuropathy, hypertension, rib disorder, reflex sympathetic dystrophy, fibromyalgia, respiratory disorder, and skin condition, to include psoriasis, have been denied.

The Board remands the claims for service connection for psoriasis, an initial compensable rating for hypertension, and a TDIU due to service-connected disabilities for further development.

The Board denied a compensable disability rating for pseudofolliculitis barbae as the Veteran's condition did not meet the criteria for a higher rating under the applicable diagnostic code.

The Board remands the claims for service connection for a respiratory disorder, claimed as asthma; a skin disorder, to include pseudofolliculitis barbae; erectile dysfunction; and a gastrointestinal disorder, claimed as GERD, for further development.

The Board granted service connection for diabetes mellitus type II as secondary to posttraumatic stress disorder with unspecified insomnia disorder and other service-connected disabilities, an effective date of March 8, 2022, for tinnitus, denied an earlier effective date prior to January 30, 2020, for sleep apnea, and granted a 30 percent rating for pseudofolliculitis barbae, effective August 27, 2019.

The Board denied service connection for bilateral tinea pedis, bilateral flat feet, and bilateral plantar fasciitis as the evidence did not support a finding that these conditions were incurred in or caused by military service.

The appeal was dismissed for untimeliness, and service connection claims were denied or remanded based on the evidence of record.

The Board remands the case for an aid and attendance examination to assess the Veteran's functional impairment due to his service-connected disabilities.

The Board remands the veteran's claims for further development and to obtain additional evidence.

The Board denied the Veteran's claims for initial compensable ratings for alopecia areata, cerumen impaction, pseudofolliculitis barbae (PFB), and hypertension.

The Board denied a compensable disability rating for the Veteran's service-connected dermatitis, finding that the evidence does not support a rating greater than 0 percent.

The Board denied an initial compensable rating for pseudofolliculitis barbae as the evidence did not show that the condition met or more nearly approximated the criteria for a higher rating.

The Board denied the veteran's claims for earlier effective dates and increased ratings, as well as service connection for various conditions.

The Board denied the Veteran's claim for a compensable evaluation for pseudofolliculitis barbae as the evidence did not support a higher rating.

The Board granted service connection for eczema, finding a link between the Veteran's current condition and his active service at Camp Lejeune.

The Board granted annual clothing allowances for the use of Clotrimazole and Triamcinolone but denied it for Mupirocin in 2020.

The Board remands the claims for service connection and initial disability ratings for a low back disability, GERD, tension headaches, and acne due to inadequate medical opinions.

The Board denied service connection for hallux valgus of the right foot, tinea pedis, and hypertension because these conditions had their onset during a period of active service determined to be dishonorable for VA purposes.

The Veteran was granted a 60 percent rating for chronic contact dermatitis from October 10, 2013, but the claim for a higher rating was denied. TDIU was granted during a specific period.

The claim for a disability rating in excess of 30 percent for tinea versicolor from August 30, 2002, to August 25, 2003, is remanded for additional development.